Actimed Therapeutics
Stefan Wohlfeil, MD, has over 35 years of experience in the pharmaceutical and biotech industry. Most recently he was Chief Medical Officer and Head of R&D at Vifor Pharma with responsibility for preclinical and clinical R&D, regulatory and medical affairs as well as drug safety. Prior to that he was Head of Clinical Research at Novartis OTC. He also has experience as founder and CEO of two start-up companies in the oncology area, one of which was based in Tokyo. Stefan started his career at Bayer Pharma, where he worked for over 20 years in discovery research and preclinical and clinical development in Germany, USA and Japan. Stefan holds a Medical Doctor’s degree from the University of Düsseldorf, Germany.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Actimed Therapeutics
Actimed Therapeutics is focused on bringing innovation to the treatment of cachexia with a vision to transform care for under-served and vulnerable patient population, prolong and improve the quality of their lives, restore their dignity and ease the burden for the patient, care and provider.